cymbalta - Drivetime Radio

Eye disordersVery rare: Glaucoma.Hepatobiliary disordersVery rare: Alanine aminotransferase (ALT) increased, alkaline phosphatase increased,aspartate aminotransferase (AST) increased, bilirubin increased.Very rare: Hepatitis, jaundice.Isolated cases of liver failure, including fatal cases, have been reported. A majority ofthese cases have been reported in patients with past or current risk factors for liver injury,including alcohol abuse, hepatitis or exposure to drugs with known adverse effects on theliver. (see PRECAUTIONS)Immune system disordersVery rare: Anaphylactic reaction, hypersensitivity.Metabolism and nutrition disordersVery rare: Hyponatraemia. Hyperglycaemia (reported especially in diabetic patients)Musculoskeletal and connective tissue disordersVery rare: Trismus.Nervous system disordersVery rare: Extrapyramidal disorder, paraesthia (including electric shock-like sensation)upon treatment discontinuation, serotonin syndrome, seizures, restless legs syndrome,seizures upon discontinuation.Psychiatric disordersRare: Hallucinations.Very rare: Mania, aggression and anger (particularly early in treatment or after treatmentdiscontinuations).Renal and urinary disordersRare: urinary retention.Reproductive system and breast disordersVery rare: Gynecological bleeding, galactorrhea, hyperprolactinemiaSkin and subcutaneous tissue disordersRare: Rash.Very rare: Angioneurotic oedema, Stevens-Johnson Syndrome, urticaria.Vascular disordersVery rare: Orthostatic hypotension (especially at the initiation of treatment), syncope(especially at initiation of treatment), hypertensive crisis.Cymbalta PI Nov 2012 v8.0 27